Warren Woessner is a registered patent attorney and a founding shareholder of Schwegman, Lundberg & Woessner. His practice focuses on chemical patent law, including biotechnology, pharmaceuticals, vaccines, medical treatments, diagnostics, and biofuels and agricultural chemistry, including related opinion and licensing matters.
Warren received his B.A. in chemistry (1966) from Cornell University, his Ph.D. (organic chemistry, 1971) and his law degree (J.D., cum laude, 1981) from the University of Wisconsin – Madison. From 1972-1978 he worked for Miles Laboratories in new drug research. Warren was an associate attorney at Kenyon & Kenyon from 1981-1984, and then joined Merchant & Gould in Minneapolis. He founded their chemical practice group and became a partner in 1989. Warren also co-founded the Biotechnology Committee of the Minnesota Intellectual Property Law Association. He has published and spoken widely on legal topics, was the 1993-1995 chair of the Chemical Practice Committee of the American Intellectual Property Law Association, chaired the Biotechnology Committee (2003-2005) and has served as a member of the Amicus Committee. He co-authored the AIPLA amicus briefs to the Federal Circuit and the Supreme Court in J.E.M. Ag Supply v. Pioneer Hi-Bred. Warren is a Certified Licensing Professional
More Legal and Business Bylines From Warren Woessner
- Patent Office Broadens “First Action Interview” Pilot Program - (Posted On Wednesday, May 18, 2011)
- What Were They Thinking? A Second Look at Lilly v. Sun - (Posted On Sunday, May 08, 2011)
- Appeals Court Overturns Stem Cell Ban - (Posted On Monday, May 02, 2011)
- Patent System Fosters Eugenics – What Next? - (Posted On Wednesday, April 27, 2011)
- Fixing The Holes – Proposed Patent Reform Bill Amendment De-Bugs Grace Period - (Posted On Wednesday, April 13, 2011)
- Myriad Oral Arguments – Section 101 vs. Chemistry 101? - (Posted On Wednesday, April 13, 2011)
- Microsoft V. i4i – Prosecution And The “Variable Proof Regime” - (Posted On Monday, April 04, 2011)
- One Step Towards an EJC Decision on the Patentability of Embryonic Stem Cells in Europe - (Posted On Saturday, April 02, 2011)
- Banning Stem Cell Research — Or Cloning? Or Both? - (Posted On Friday, April 01, 2011)
- Innovation Toys And Analogous Art – Defender Against Hindsight? - (Posted On Friday, March 25, 2011)
The National Law Review has awarded Warren Woesssner, shareholder at Schwegman, Lundberg & Woessner, P.A., a Go-To Thought Leadership Award for Mr. Woessner’s ongoing coverage and analysis of patent disputes, updates to USPTO processes and interviews and profiles of prominent federal agency appointees. He provides NLR's readers with a well-rounded view of issues impacting patent law in the U.S. The cases of Yu v. Apple and CareDx v. Natera are especially notable, detailing the complicated intersections between intellectual property, technology, and health law.
Warren Woessner and his thought leadership on Life Sciences Intellectual Property has been selected for a National Law Review Go-To Thought Leadership Award. Mr. Woessner’s coverage of patent litigation, the Patent Trial and Appeals Board and the Court of Appeals for the Federal Circuit and how those decisions fit into the larger landscape of patent litigation is an invaluable resource for NLR readers. You can subscribe to his Patents 4 Life blog here.